Taguchi M, Yokota M, Koyano H, Endo Y, Ozawa Y
Department of Endocrinology and Metabolism, Toranomon Hospital, Tokyo, Japan.
Clin Endocrinol (Oxf). 1999 Nov;51(5):667-70. doi: 10.1046/j.1365-2265.1999.00888.x.
A wide variety of adverse effects of methimazole (MMI) have been reported. Here we report a new MMI-induced disorder, acute pancreatitis and parotitis. Three weeks after a woman started MMI treatment for Graves' disease, she developed a high fever, painful parotid swelling and dull pain in the upper abdomen with elevation of the serum levels of salivary and pancreatic enzymes. These abnormalities disappeared soon after the withdrawal of MMI. However, the same abnormalities were rapidly provoked when MMI was reintroduced. Marked increases in the leucocyte count and CRP were also observed during these episodes. The possible mechanisms of MMI-induced pancreatitis/parotitis are discussed.
已有多种关于甲巯咪唑(MMI)不良反应的报道。在此,我们报告一种新的由MMI诱发的病症,即急性胰腺炎和腮腺炎。一名女性因格雷夫斯病开始接受MMI治疗三周后,出现高热、腮腺肿痛以及上腹部钝痛,同时唾液和胰腺酶的血清水平升高。停用MMI后,这些异常情况很快消失。然而,重新使用MMI时,同样的异常情况迅速再次出现。在这些发作期间,还观察到白细胞计数和CRP显著升高。本文讨论了MMI诱发胰腺炎/腮腺炎的可能机制。